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“Teratology in the 20th Century Environmental Causes of Congenital Malformations in Humans and how they were established.”

By:  Harold Kalter

Important information is presented in a beautifully written preface with regard to the incidence and frequency of spontaneous abortions, congenital malformations, and malformed infants or fetuses that are lost early or late in pregnancy. Unfortunately, there is not a single citation to support all of the information that Kalter presents in the preface. The preface ends with the following statement. 
“This article summarizes the past and the latest findings and opinions about the environmental—that is, nonhereditary—teratological forces that malform the unborn creature between the moment of conception and birth.”
The first seven pages of the Introduction deal with definitions. Kalter has selected quotes from a number of articles of scientists in the field who have defined malformations. While he has quoted a number of these scientists and left out scores of others who have defined congenital malformations, he did not mention the Centers for Disease Control’s (CDC) definition. The CDC’s definition is the basis for the epidemiology of the frequency, incidence and prevalence of congenital malformations, which is documented by their periodic reports in publications from the former Congenital Malformation Surveillance branch of the CDC. 
Kalter discusses the various classifications of malformations including classification by pathogenesis, a discussion of nomenclature, taxonomic innovation and the developmental field concept. He is not very supportive of all of these methods of classifications and concludes this section of the review with the following statement. “Returning to the ambitious systems outlined above, it does not seem, some decades later, that the aspiration entertained of the new scheme of nomenclature—that classifying multiple malformations patterns based on the hypothetical morphogenetic relations of their constituent parts would permit “analysis of birth defects” and lead to preventing congenital malformations has had any success.” In essence, Kalter does not believe that all of these methods of classification are going to be very helpful in determining the etiology of birth defects in humans.
In the next section of the review article, Kalter discusses the frequency of congenital malformations. He emphasizes an important point, which happens to be a quote from Warkany in 1947, “A clear and commonly accepted terminology is indispensable for a satisfactory discussion of a subject.” That is probably the most important line in this section dealing with frequency, since you cannot know the incidence, prevalence, or frequency of malformations unless the people who are recording the incidence, prevalence, and frequency agree on the terminology.
From pages 15 to 18, Kalter goes into more detail about the frequency of malformations. He discusses multiple facets of the frequency problem, 1) the difficulty we have had in naming malformations, 2) the problems of determining how often malformations occur, 3) the issue of defining the severity of malformations, 4) the matter of underestimating the frequency of malformations in past studies, and 5) overestimating the frequency of malformations. Throughout this section of the discussion of the frequency of malformations, there is no mention of the important role of the Congenital Malformation Surveillance Branch of the CDC. They really established the concept of recording the frequency of “severe” malformations. In the multiple quarterly reports from the Congenital Malformation Surveillance Branch to the periodic yearly and decade summaries of the frequency of malformations, the definition of severe malformation is inherent in their reports. The group of scientists at the CDC has made major contributions not only in their own studies but also by supporting other epidemiological groups across the country in determining the frequency of malformations. This section on frequency is a lengthy, wordy section. It could be reduced markedly and still get all of Dr. Kalter’s important points across. In the last paragraph Kalter mentions congenital malformation registries and comments about their impact. He says, 
“The main function of registries supposedly is to alert to impending malformation epidemics and hopefully to avert them, purposes they hope to achieve by monitoring malformation births through ongoing or periodic gathering of information from various overlapping sources in larger or smaller geographic areas. Whether it is luck or chance or the ascertainment uncertainties and limitations by which they are beset that have so far kept them from detecting malformation trends, much less epidemics, is an open question.” 
It is not clear whether Kalter believes this quotation since he cites Stone and Hamilton (1987) as the source. However, registries have been an important part of our understanding of the frequency of malformations. More important, if you look at the Congenital Malformation Surveillance Branch, their data has been very helpful in refuting allegations of teratogenicity when larger data bases such as the CDC’s program can be used to check on smaller epidemiological studies that infer some type of association, when none exists.
The next section of the review article deals with Early Human Studies. From pages 18 to 22, Kalter discusses radiation effects on the developing embryo. He points out that animal experiments in the rabbit were reported in 1907 indicating that ionizing radiation could produce congenital malformations. In reviewing the animal and human literature, Kalter states that, 
“The contrast between animals and humans in this respect is amply illustrated by the detailed knowledge of these relations in the former and their paucity in the latter.” 
In this quotation, he lists as references, Russell, Hicks, and D’Amato, and himself although his article is a review. He has done no experimental work in this area. For the human data he lists Dekaban, which of course, was a paper that dealt primarily with radiation therapy in pregnant women. While he mentions Wilson and Karr in 1951, he does not mention the series of wonderful papers by Dr. Wilson that meticulously studied the stage and dose problem with regard to radiation teratogenesis in the rat. Nor does he mention the extensive work of Robert Rugh or our own laboratory, which published numerous articles dealing with experimental work and reviews on the subject of radiation teratogenesis, ionizing radiation, ultrasound, microwaves, and electromagnetic fields. 
Kalter appears to be puzzled by the difference between human and rodent sensitivity to radiation teratogenesis. He says, 
“In human beings, however, irradiation causes a much smaller assortment of abnormalities as will be discussed below for reasons that are not clear.” 
In fact, the explanation of the difference in reported malformations in the human and in animal species is quite simple. Animal experiments are planned with timed pregnancies and are irradiated on a specific day with a variable range of dosages. Human exposures to radiation primarily occurred from protracted high-dose radiation from radiation therapy or from the acute exposure of the atomic bomb. The explanation as to why chronic exposure to high dose radiation from radiation therapy did not result in the spectrum of malformations seen in the rat should be obvious. Radiation therapy administered in the papers by Goldstein and Murphy and by the review article by Dekaban were given over a period of weeks. If the exposure occurred during early organogenesis, the most likely result would be loss of the embryo, since the LD-50 of an embryo from the period of 20 to 30 days post-conception is extremely low. Therefore, most of the embryos that would be sensitive to radiation teratogenesis of the central nervous system, heart and limbs, which can be produced in the animal model, would never been seen in the human following high dose chronic exposures that included early organogenesis. With regard to the atomic bomb, the same thing is true but for a different reason. If you had 100 rad to 125 rad exposure during that early post-conception period of 20 to 30 days, those embryos wold be lost. But the other reason why they did not see the typical spectrum of early organogenetic malformations in the human is that the exposure was not administered to humans at specific time of gestation. There were over 1,000 pregnant women in Hiroshima and Nagasaki and they were spread evenly through the entire period of gestation. So, only a very small percentage of women were at the stage of early organogenesis. That small percentage who received dosages in the teratogenic range very likely lost those pregnancies and may not even have known that they were pregnant. The ones that survived with malformations also would have a great likelihood of aborting. The ones that did survive without malformations because of lower exposures would not have microcephaly and mental retardation because the early embryo has tremendous recuperative powers. Although you can destroy the early potential neurons during early organogenesis, if the embryo survives, they can be completely replaced. While the destruction of cells that are going to become neurons in the midgestation period, once destroyed are not replaced and that is why microcephaly occurs more readily from the period of the 8th week to 15th week of gestation.
Kalter did not discuss the importance of fractionation and protraction in modifying the effects of radiation teratogenesis. Brizzee (1972) demonstrated that fractionation of the radiation markedly reduced the effect on the central nervous system when rats were exposed on the 12th day  of gestation. One hundred-fifty rads administered to the 12th day old rat embryo could reduce the important cortical layers of the brain in the rat by 60%. But, if that same dose was fractionated into 9 fractions over a period of 12 hours, you could not tell the controls from the irradiated. A publication by Brent (1999) reviewed the studies demonstrating that protraction of the radiation could markedly reduce the teratogenic effect. This is important clinically because much of the radiation exposures in the diagnostic range are spread over a period of days and are protracted and fractionated. This is especially true when radioisotopes are administered either for diagnostic tests or for therapeutic purposes; namely, the radiation is protracted.
The other groups of papers that Dr. Kalter ignores are the papers dealing with the indirect effect of radiation. In my earlier years in the field of radiation embryology, frequent calls would come into the laboratory because of the fears of patients that radiation of other parts of the body might affect the developing embryo. To most scientists this would seem an unlikely result; namely, that radiation of the pregnant mother’s head could produce malformations in a developing embryo. The concern and anguish by many of the patients who called was quite evident. Even today, about 10 to 20 percent of the consultations that we receive on the Health Physics Web site of “Ask the Expert” are from women who are pregnant and have had an exposure to other parts of their body. In 1960, we began a series of experiments because we felt that this was an important question to answer even though it was not what I would call sophisticated research and we published a series of five papers. We looked at the indirect effects of radiation on the embryo on the 9th, 12th, 1st day using whole body radiation of the pregnant rat, radiation of the whole rat while shielding the ovary, radiation of the whole rat and radiation of the placenta while shielding the embryo. The results were just as you would expect; namely, that if you want to malform the embryo, you have to radiate the embryo (Brent 1960, Brent and McLaughlin 1960, Brent and Bolden 1967a and 1967b).
With regard to the stage of sensitivity of the mammalian embryo or the human embryo, Kalter says, “So far as time was concerned, irradiation caused malformation only from the third to the fourth through 19th week of gestation with severe abnormalities especially cataract and microcephaly occurring only before the 17th week.” It is interesting that Kalter makes no comment about the first two post-conception weeks with regard to its sensitivity to radiation teratogenesis. The reason why I mention that is there is an extensive literature on this subject. Russell, Wilson, and Brent described the so-called all-or-none period in the early 1950’s. This was a stage from conception to preorganogenesis when irradiation either killed the embryo or resulted in a group of embryos with the same incidence of malformations as the unirradiated embryos. In fact, the paper by Wilson, et al. published in 1953 determined the timing during rat gestation when the embryo converted from resistance to teratogenesis to a marked sensitivity to teratogenesis and it was at 8 days and 4 hours. The fact that the embryo during the preorganogenetic period was resistant to radiation teratogenesis and very sensitive to the lethal effects of radiation was demonstrated in multiple publications.
This is an important clinical concept because surprisingly about 10% of the consultations that we get on the Health Physics Website include women who have had their diagnostic radiological exposure during the preorganogenetic period. You can understand why this might happen since they did not even know they were pregnant at the time of the radiation exposure.
Kalter mentions the consensus in the medical literature that 5 rad or less of x-rays poses no threat to structural development or only a negligible one. There is an extensive series of papers dealing with the discussion of this issue, which Kalter ignores. He does not mention the history of the 10-day rule and the rebuttal of the 10-day rule or Handbook 54 of the National Council on Radiation Protection and Measurements (NCRP), which was published in 1977. To attribute the decision that 5 rad was the no-effect dose to Mole is not correct. The conclusion that the 5 rad exposure as a conservative no hazard dose for malformations or miscarriage was determined by a group of scientists working together in many discussions and it culminated with Handbook 54 of the NCRP, which was published in 1977 (Brent et al. 1977).
In another section, Kalter discusses Murphy’s contribution. He pointed out something of interest; namely, that Murphy and Goldstein were the first to discover a human environmental teratogen. Obviously, this is true since their papers were published in 1928 through the early 1930s. But then Kalter makes an interesting comment, 
“Murphy died in 1971 at 78 years of age and is remembered as a busy physician, obstetrician, teacher, gardener, pipe-smoker, but strangely not as a groundbreaker in the field of human teratology.” 
This should not be a surprise to anyone, since having an impact on the scientific community and clinical medicine takes a lot of effort and energy. Writing papers is the first step. If you believe that you have made an important discovery and one that could improve the healthcare of the nation, then you have to do more than write papers. You will note that Kalter says that Murphy was a teacher, gardener, pipe-smoker that was not recognized as a groundbreaker. The reason is simple. If you want to break ground in a democratic society you have to make a major effort in multiple areas to convince the medical, scientific, political and lay community that the discovery could be beneficial. In order to protect pregnant women, safeguards should have been put into place to prevent radiation of women who were pregnant. There are many instances where scientists have done exactly that. In this particular review, Kalter refers to Oakley and the issue of folic acid and neural tube defects. Oakley was not the discoverer of relationships of folic acid to neural tube defects, but he realized its importance and he has spent the last decade tirelessly working in many areas to convince the nation that folic acid supplementation is an important issue. He has testified before Congress. He has written letters to the editor. He has pleaded with societies to be more active with regard to this issue and write to congressmen and the FDA and many other governmental agencies. It takes an immense effort and a tireless individual to convert an article or articles in the literature into action that helps the population. You can write as many articles as you want, but if you feel that the issue is important, then you have to work tirelessly, probably over many years to have an impact on society and medical care.
In reviewing the Hiroshima and Nagasaki data, there appears to be some inconsistencies in Kalter’s conclusions. In one paragraph, Kalter says, “Almost all the microcephalic children were mentally retarded.” In other parts of the review, he indicates that there were children who were microcephalic who were not mentally retarded. Kalter does not clarify the controversy over whether mental retardation was a threshold phenomenon or a stochastic phenomenon following radiation exposure during pregnancy. The 1984 paper by Otake and Schull published the conclusion that 1 rad of radiation (which is in the diagnostic range) could double the incidence of severe mental retardation. The scientific consensus among other radiation biologists and epidemiologists was that Otake and Schull were wrong, but Otake and Schull persisted with that conclusion until the early 1990s when a number of experiments both in animal and clinical studies refuted their original conclusion published in l984. Kalter does mention two of the papers that appeared in the NCRP symposium dealing with radiation effects on the embryo, which appeared in the April issue of Teratology in 1999. The paper by Miller (1999) concluded exactly what Kalter listed in his paper; namely, that no mental retardation occurred below 0.57 Gy. In other words, Miller has a much higher threshold than Otake and Schull. By the way, the Miller paper is cited but it is not in the references. The Otake and Schull (1999) paper published in that same issue in Teratology does conclude that there is a threshold. There was important animal evidence that supported Miller’s view and that was the work by Jensh, et al. 1986, 1987, Jensh and Brent 1988a,b. This series of animal radiation papers supported exactly what was found in Hiroshima and Nagasaki; namely, that mental retardation is very difficult to produce even with high dosages of radiation during the period of early organogenesis but that neurobehavioral effects can be produced later in gestation and that there was a threshold at 20 rads for neurobehavioral effects.
Anyone who has done radiation embryology experiments and looked histologically at the embryos can understand why mental retardation is difficult to produce during the period of early organogenesis. If you give a dose of radiation that does not result in anatomical defects, such as, hydrocephalus, encephalocele, spina bifida, or anencephaly and the architecture of the brain is normal, within 24-48 hours after radiation there is marked cell destruction due to the cytotoxicity of the radiation. But, at this early stage of gestation, there is also a tremendous recuperative power in both the cerebellum and the cerebrum during this early period and the embryos are able to replace the cells almost completely. So Otake and Schull’s conclusion that mental retardation is difficult to produce during early organogenesis is supported by animal research.
Kalter concludes the section on radiation effects of developing embryos with a short paragraph. He had a tremendous opportunity to bolster the Teratology Society’s contribution to this area because the same symposium that had Drs. Miller, Schull and Otake’s paper had a series of papers on low frequency electromagnetic fields, microwave, and ultrasound and he could have included all of those references with a brief summary of their conclusions. There is no mention of the fact that microwaves can produce congenital malformations if you raise the temperature of the embryo, just as ultrasound can do the same. But, in the diagnostic range and at levels below hyperthermia, they do not seem to have the potential for producing congenital malformations. Apparently, the reason for this very short section is because Dr. Kalter does not feel that any of these other forms of radiation are potential human teratogens. While the scientific community agrees with him, the press, many lay individuals, and even elements of the government are concerned about the potential teratogenicity of some of these non-ionizing radiation modalities and that can be a hazard in itself.
The section on Rubella gives a very clear picture of the story of Dr. Gregg and his discovery of the cause of congenital malformations following maternal infection with the Rubella virus. There is a lengthy digression dealing with the importance of the stage of pregnancy or the exposure, as to which is more important. It is interesting that Kalter would put this discussion of the importance of stage and dose in the Rubella section, since one cannot readily control the dose of the virus, since it replicates. In dealing with the infectious diseases that cause malformations on pages 26 and 27, Kalter mentions cytomegalic inclusion disease, varicella, Rubella, and toxoplasmosis. But, he fails to mention Venezuelan equine encephalitis, syphilis, rare teratogenic or reproductive effects of Coxsackie viruses, herpes simplex viruses, and parvovirus. He also does not mention the historical argument over whether there was an HIV teratogenic syndrome and the fact that most HIV infections occur perinatally and cause the child to have central nervous system disease, growth retardation, and eventually early death. There are cases of intrauterine infection with HIV but, the predominant source of infection is during the course of delivery. The suggestion that there was such an entity as the HIV teratogenic syndrome is not supported by the data.
While Kalter eloquently coveys the history of the discovery of Rubella teratogenesis, the reader gains no historical perspective regarding the discoverers of the other teratogenic or reproductive harmful infections.
The next section deals with the review of the animal research of Hale and Warkany demonstrating that nutritional deficiencies could result in congenital malformations. On page 30, Kalter describes the principles of teratology. These principles primarily relate to animal research since principles of teratology as they relate to human teratogenesis should include a concept of the syndrome and the fact that there are genetic etiologies in the human that can mimic the teratogenic syndrome and vice versa. Furthermore, the nature of malformations following an exposure can refute an allegation that a particular drug was responsible for congenital malformations even if it is a known teratogen. 
Principle #1 states, “Susceptibility to teratogenesis depends on the genotype of the conceptus and the manner in which it interacts with adverse environmental factors.” This varies greatly with the teratogenic agent. For example, ionizing radiation, since it directly affects the embryo, has very similar consequences in most mammalian species because you are not dealing with differences in metabolism, absorption, excretion, and placental transport. Species differences introduce a multiplicity of factors that include differences in metabolism, excretion, absorption and placental transport that may alter the teratogenic effect and teratogenic dose of a particular agent. In fact, we have instances in which an agent is not teratogenic in one species but it is potent teratogen in another, i.e. thalidomide.
On page 32, Kalter discusses the teratogenicity of Trypan Blue. He mentions the theory of Gillman et al. 1951 and Wilson 1959 as to how the teratogen worked. But Kalter felt that their explanations were not valid or were at least unclear. He also refers to the work of Beck and Lloyd (1966) and he says that their studies were clearly inadequate to the task of resolving the nature of the proximate step, the one that leads directly to the induction of specific malformations. 
Unfortunately, Kalter did not follow the story to its end. Beck and Lloyd and the colleagues in their laboratory did further experiments to indicate that Trypan Blue interferes with pinocytosis of maternal serum proteins, thus depriving the embryo of the amino acids present in the maternal proteins and producing a form of embryonic malnutrition. This story was further advanced by other agents, which interfere with pinocytosis (Lloyd and Beck 1969, Lloyd 1967, 1971, 1976, 1982, 1990, 1997). 
Following the discussion of Trypan blue, Kalter summarized the history of hypoxia induced teratogenicity, a short paragraph about Down syndrome, cortisone studies in animals, induced and spontaneous malformations, genetics and individual responses, the multifactorial threshold concept, new concepts of embryotoxicity and finally, vitamin anti-metabolites, folic acid, and folic acid antagonists. The content of these sections seemed isolated and not interrelated at all. He closed this section with a few paragraphs about the Teratology meetings and the origin of the Teratology Society without mentioning Shepard, et. al. (2000) recent historical review. 
From page 37 to 43, Kalter describes the history and many facets of the thalidomide story. It is a section worth reading especially for the younger scientists in the field of teratology. Section 10 deals with the “Testing for Teratogenicity.” On page 44, Kalter discusses the topic of teratogens and mutagens. The discussion pertains to the period before organogenesis begins and the fact that certain agents, especially potent mutagens can result in malformations when given at high doses during this early period of development. The discussion really does not get into the basic science of the experiments of Generosa, Rutledge, and Polifka or Streffer. The fact that these agents did not produce teratogenesis as we usually observe it but resulted in specific malformations was interesting and should have been discussed by Kalter because it is the most important result of their research and why the term “epigenetic effect” was given to these results.
On page 46, Kalter discusses the concept of alleged teratogenicity and focuses on Bendectin. Since this is a topic that was one that consumed significant amount of my time from 1980 to 1997 and that I had written numerous articles, editorials and finally two review articles on the subject, it was surprising that Kalter failed to mention these articles in his review (Brent 1995, 1997, 2002). Of course, I would not expect him to include the 2002 article in this particular review since he was talking about the last century but it is the article that put the final nail in the coffin of the Bendectin controversy because in that same issue there was an article by Steven Lamm’s group pointing out the consequences of the Bendectin litigation and removing the drug from the market.
Kalter spent three pages of his review dealing diethylstilbestrol, which is one of the fascinating stories of the 20th century. For some reason, he indicates that DES was given because some investigators thought that spontaneous abortions were due to progesterone deficiency. It is true that some investigators thought that spontaneous abortions were due to progesterone deficiency but diethylstilbestrol or DES is not a progestin, but an estrogen substitute and the reason why it was used, is because Smith and Smith and others at the Boston-Lying-In felt that it produced much healthier placentas. There is a brief review of the DES story listing many of the publications of Herbst and his colleagues. The most important publication was the 1971 article in the New England Journal, in which the Herbst’s group reported that there was a strong association between the administration of DES in pregnant women and the occurrence of adenocarcinoma of the vagina in adolescent girls. The second most important paper of Herbst is listed in the bibliography but not referenced or discussed in this section on DES. That is the paper that was published in Cancer in 1970. Herbst reported these same seven cases of clear cell adenocarcinoma of the vagina in 1970 but did not have an etiology. The publication in Cancer just reported this rare tumor in adolescent children. It was between 1970 and 1971 that it was brought to Herbst’s attention that these mothers had received DES. In the 1972 paper, Herbst created the registry and the whole field of research in this area. Kalter summarizes the DES story with the following statement, 
“Final remarks about this medical episode can be brief. Fifty years after the fad began of treating pregnant women with a non-steroidal estrogen for the purpose of preventing pregnancy complications—never proven efficacious—the suspected harmful effects on especially female offspring exposed prenatally to the substance were found to be negligible, transitory, unproven, or nonexistent; the one possible actual effect—a seldom occurring vaginal cancer—has disappeared from history with the aging of the supposedly affected exposed cohort.”
This is an amazing summary paragraph in view of the fact that it is clear that female fetuses exposed to diethylstilbestrol in utero did have some congenital malformations of their genital tract, which interfered with their fertility or ability to carry babies to term. Admittedly, as Dr. Kalter points out the frequencies of these problems were small but they were clearly statistically significant. There were other “findings” in the DES population of interest such as, infertility, cancer of the breast, uterus, or other organs, which have not been confirmed as Dr, Kalter indicates. The problem of adenosis was not of great clinical significance but it did promote anxiety in the patients who were followed with this problem, since in the early days it was not clear whether there was an association between adenosis and the eventual occurrence of clear cell adenocarcinoma or other reproductive problems. Only time indicated that adenosis was a relatively benign condition. 
On page 51, Kalter describes the surveillance of congenital malformations. He describes a number of investigators and agencies that were involved in surveillance and monitoring, including the International Clearinghouse for Birth Defect Monitoring. But, for some reason, he ignores the Congenital Malformation Surveillance Branch of the CDC, which has been extremely important in providing information concerning the frequency of birth defects and the ability to examine their data for a possible etiology, because of the other reproductive data the CDC collected. Monitoring for birth defects can have etiological results if other information is collected such as, drugs, chemicals, and other environmental exposures along with the frequency of malformations. This occurred in Lyon, France when Elisabeth Robert (Robert and Guibaud 1982) discovered valproic acid teratogenesis. So, historically we do have one epidemiological monitoring program that resulted in the discovery of a teratogen. 
The next section deals with human diseases as teratogens. From pages 56 to 60 the topic of phenylketonuria is discussed. Maternal phenylketonuria and all its consequences are presented in great detail with regard to mental retardation, and congenital malformations in the offspring of PKU homozygous mothers. 
From pages 60-66, Kalter discusses insulin-dependent diabetes mellitus and its role in the etiology of congenital malformations. In the introduction to this section Kalter says,
“Pregnancies of diabetic women have been prone to various detrimental outcomes—increased perinatal mortality, increased SAB, large babies, and congenital malformation.” 
In the rest of the presentation, Kalter points out that many of the studies are faulty from both an epidemiological and clinical standpoint. He appears not to be certain as to whether insulin-dependent diabetes is related to a significant increase in congenital malformations and other reproductive effects. His final paragraph in this section states, 
“With regard finally to malformations in surviving offspring, the evidence clearly demonstrated that congenital malformations were not increased in the children of diabetic women.”
He certainly is in the minority on this subject since the scientific community and the clinical obstetric community has long believed that insulin-dependent diabetes is a teratogen and has other reproductive deleterious consequences. Furthermore, studies indicating that meticulous control of diabetes during pregnancy has reduced the incidence of malformations. Apparently, Kalter disagrees with these conclusions. 
Kalter’s discussion of hyperthermia ends with the following statement, “The recent ‘teratogen update’ on the subject of hyperthermia (Graham et al. 1998) began with a bang.” The opening sentence stated authoritatively that “[H]yperthermia was the first teratogen in animals that was subsequently proven to be teratogenic in humans.” It is to be hoped that these authors will read this book and learn how wrong it is possible simultaneously to be on so many counts.” Kalter does not seem to mince words. It will be interesting to see Graham’s response to Kalter’s critique when the review is published. 
Iodine deficiency teratogenesis, and organic mercury teratogenesis are discussed and are clearly presented. 
Kalter discusses the teratogenicity and mutagenicity of Agent Orange from pages 70 to 75 and he does an excellent job of presenting the scientific, political, and emotional aspects of this environmental toxicant. He is critical of the Institute of Medicine’s study dealing with the reproductive effects of Agent Orange and I think his criticism is justified. Kalter’s discussion of the variability of the sex ratio and the factors that may affect the sex ratio should be of great interest to reproductive biologists. He develops a very interesting and stimulating presentation regarding Agent Orange. He probably could have strengthened his opinions and conclusions if he had looked at some of the animal work. If you recall, Agent Orange has a LD50 that is greater than many over-the-counter drugs. In other words, it is not a very toxic compound to mammalian organisms. 
On pages 75 and 76, Kalter discusses the industrial accident that occurred in Seveso, Italy where TCDD was released over a wide area and the reproductive effects were evaluated over a period of months and years after the explosion. Kalter’s final analysis is that exposure to levels of TCDD experienced in Seveso did not result in a teratogenic outcome. Of course, the other major concern in Seveso was the oncogenic effect, which has been followed for a number of years and was not the responsibility of Dr. Kalter to discuss in this particular review article. One other interesting thing is that animal studies with TCDD or dioxin indicate that teratogenesis does not occur until you reach toxic levels in the maternal organism. Apparently, that would backup the low risk for birth defects or no risks for birth defects in Seveso, since maternal toxicity did not appear, except for chloracne. 
In the discussion of the Sellafield data, which is a nuclear processing facility on the east coast of the United Kingdom, there were publications that suggested that there was an increased in birth defects and oncogenesis in the population surrounding the plant and in the workers. The data was not consistent and the positive epidemiological studies were critiqued by a number of epidemiologists and radiation biologists. In fact, James Neel, the geneticist from the University of Michigan wrote an extensive review of the subject and came to the conclusion that the data from Sellafield did not support any type of preconception reproductive or oncogenic risk. The Sellafield issue is not a teratogenic issue but a genetic issue concerning the genetic effect of an environmental toxicant; namely, radiation of the sperm of the males in the area around Sellafield.
 The PCB prenatal toxicity effects are discussed on pages 77 to 79 and are dealt with by Kalter extremely well. It is a very balanced and fair presentation of the issues and he clearly differentiates between the Cola-colored baby toxicity in the orient and the low-level exposures that occurred in other places in the world. Kalter obtained the information on the Love Canal from a Website dealing with topic, which can be viewed on-line from the archives of the State University at Buffalo. The story is an interesting one and should  be read by all reproductive biologists and geneticists. It emphasizes how erroneous information, the news media, and the government can make a bad situation much worse by failing to get accurate data about population effects.
From pages 80 to 94, Kalter discusses the effect of drugs on embryonic development. The section is labeled, “Disease medication and teratogenesis.” He has an extensive review of the retinoids and their teratogenic effects and an equally extensive review of the anticonvulsants. Kalter describes the retinoic acid embryopathy, which is attributed to isotretinoin, but he is not certain that etreinate and acitretin are teratogens. In fact he says, 
“Etreinate and acitretin nevertheless appear to differ teratologically from other retinoids by their failing to produce the full-blown retinoic acid embryopathy, and perhaps by not being teratogenic at all.” 
He also addresses the controversy over topical tretinoin use. There were a number of case reports of women who used topical tretinoin for skin diseases and delivered children with malformations. But, Kalter reviews the pharmacokinetic data, which in his opinion dose not support the possibility that topical tretinoin can raise the blood level to the point where it exceeds the threshold for teratogenesis for the human embryo. This happens to be the consensus of most scientists at this time.
Ten pages are spent on reviewing the literature dealing with the anticonvulsants. There are two interesting conclusions in his review about the reproductive effects of anticonvulsants that are surprising. His conclusion about the teratogenicity of the anticonvulsants is stated as follows, 
“A current view has been expressed that there is no clear cut agreement that anyone of the four major drugs used for the treatment of seizure disorders is more teratogenic than others, but this avoids the question of whether any of them is a major teratogen.” 
While it is true that the teratogenicity of this group of drugs does not reach the magnitude of thalidomide or isotretinon from the standpoint of the percentage of the exposed population that is affected, there is clearly a risk for severe malformations albeit in low incidence such as microcephaly, decreased I.Q., cleft-palate, and other effects. I do not think as teratologists we can ignore malformations because they are not grotesque or life- threatening. 
It is of interest that no where in the references or in the manuscript does he refer to thalidomide and valproate acid and their association with autism. I do not know whether Dr. Kalter was at the Teratology meeting when Kersten Stromland presented the series of patients from Sweden in which a small number, but a surprising number of the malformed thalidomide children exhibited autistic behavior. That opened research in the area of the etiology of autism, which indicated that rather than a cerebral cortical problem, that this was a posteria fossa or a hindbrain abnormality in the very primitive part of brain. Dr. Rodier, an outstanding scholar in the fields of autism and neuropathology has performed experimental animal work that supports Dr. Stromland’s findings. Dr. Rodier is not even mentioned in the reference list provided by Dr. Kalter.
Kalter does indicate that he would put valproate acid in the category of a major teratogen since it does produce neural tube defects. The whole concept of major or minor teratogens is meaningless when one realizes that it depends on the dose. The fact is that if you raise the dose of valproate acid above its clinical therapeutic level, you can get a higher incidence and more severe malformations. It just so happens that patients are fortunate that the therapeutic level that is necessary for valproate acid represents a low risk for neural tube defects and other manifestations of the valproic acid syndrome.
In Kalter’s detailed analysis of the teratogenicity of lithium, he concludes that as more data is obtained the risk decreases to the point where he questions that there is a teratogenic risk from a lithium exposure. In the last paragraph of the lithium section, Kalter says, 
“More than 20 years after the first suspicion arose of the prenatal harmfulness of lithium, after the disclaimer had been expressed time and time again that registry-collected cases were unreliable indicators of teratogenicity, what appears to have been the first prospective study of this difficult problem all but drove the nail into the coffin, and lithium was for all practical purposes absolved of being a teratogen.”
The last two sections of the review article from pages 94-124 deal with the teratogenic effects of low folic acid availability to the developing embryo and the matter of the fetal alcohol syndrome from maternal ingestion of alcoholic beverages during pregnancy. Kalter spends a great deal of time discussing every aspect of the folic acid issue and its causal relationship to neural tube defects.
In the last paragraph of the folic acid section, he asked the question, “Has folic acid supplementation and fortification prevented neural tube defects?” He does not categorically deny the possibility that folic acid supplementation has prevented neural tube defects, but he has a number of reasons why the decline in neural tube defects has occurred and that this decline may be unrelated to the supplementation of folic acid. But in future years when all of the data is in he suggests that, 
“The whole business of folic acid was itself only a passing fancy. Time will tell.” 
One other concern of Kalter with regard to the neural tube defect—folic acid issue, is the fact that administration of folic antagonists has not produced the syndrome of neural tube defects that is suppose to be prevented with folic acid supplementation in the human. In reviewing the literature, Kalter points out that only a small percentage of human embryos exposed to folic acid antagonists ended up with classical neural tube defects and that the malformations described by Warkany in patients who were exposed to folic acid antagonists exhibited skeletal defects not neural tube defects. Only two of the 12 pregnancies exposed to folic acid antagonists by Thiersch had neural tube defects and many other pregnancies treated with folic antagonists resulted in pregnancy loss, but no neural tube defects. Kalter summarizes this data by stating, 
“Thus, one has every right to be puzzled by the fact that while powerful chemical teratogens have all but failed to induced these malformations in infants, ‘biochemical’ folate deficiency is postulated to be capable of doing so.” 
Two of 12 pregnancies having neural tube defects is not a low incidence. Secondly, patients with low levels of folic acid have an increased risk, but a much lower risks than the patients treated by Thiersch. Secondly, pregnancy loss could be due to the induction of severe malformations. Another issue to be examined with regard to these data, is at what time in pregnancy were the folic acid antagonists administered. If they were given after the fourth postconception week then one might not expect to see neural tube defects since the neural tube would have completely closed by the 28th day postconception. In the treatment of ectopic pregnancies, or in attempts to interrupt the pregnancy, what percentage of patients were given the folic acid antagonist prior to neural tube closure. Also, what was the exposure to the folic acid antagonist since we know that the use of folic acid antagonists for the treatment of rheumatoid arthritis or other autoimmune diseases does not result in congenital malformations because the dose is too low or below the threshold dose for teratogenesis.
Until these questions are answered, I do not think we should be puzzled by the fact that there are not a large series of patients with neural tube defects who have been exposed to methotrexate or aminoptrein, since the time of exposure would be crucial in determining whether NTD’s could be produced.
The final discussion by Kalter deals with the effects of alcohol on the developing embryo. Both the folic acid section and the fetal alcohol section have extensive references which is a valuable component of Kalter’s history of teratology. Just as Kalter is unimpressed with the importance of folic acid supplementation in the prevention of neural tube defects, he is not impressed with the importance of alcohol in harming the developing embryo and fetus. It is obvious that Kalter believes that the risks that have been associated with drinking during pregnancy are exaggerated. He says, 
“How can the years of work and multitude of studies of the effects of maternal alcohol drinking on embryos, fetuses, and children be judged? Are they right, are they wrong in the allegations, accusations they pose?”
Obviously, I do not agree with Kalter’s ambiguous conclusions with regard to the importance of the fetal alcohol syndrome or fetal alcohol effects. Anyone who has taken care of children who have been exposed to alcohol during their pregnancy and manifest the full blown fetal alcohol syndrome is impressed with the magnitude and severity of the central nervous system and growth retarding effects as well as the permanency of these effects in these children. In a recent study in South Africa in which Dr. Kenneth Jones was involved, they evaluated the low socio-economic population in that country and determined that the incidence of fetal alcohol effects was greater than five percent, which is a disastrous burden with which a society would have to contend. I will let scientists like Jones, Stressguth, Clarren, or many of the others who have worked in the field answer Dr. Kalter’s analysis and conclusions about the fetal alcohol syndrome.
One other important point. When we deal with controversial subjects in the area of reproductive biology or teratology, it is important to acknowledge past associations, if they exists, that might be considered conflicts of interest. For instance, when I wrote the article on Bendectin (Brent, 1995 and 1997), I pointed out that I was a consultant to the law firm that defended those cases for Merrill Dow. Similarly, in the article on progestational drugs, and its non-teratogenicity, I pointed out that I also had been a defense expert for the physicians who were sued when the plaintiffs claimed that a progestational drug had caused non-genital malformations in an infant. Kalter has not acknowledged the fact that he has participated in litigation with regard to the effects of alcohol on the developing embryo. I particularly remember the lawsuit against the alcohol industry in which Kenneth Jones, Sterling Clarren, and myself were requested to participate as experts. The law firm initiated a lawsuit against the alcohol beverage industry. In 1977, the alcohol beverage industry was unwilling to label alcoholic beverages with a warning for pregnant women. We functioned as plaintiff experts in a lawsuit in which the defendant was an alcoholic beverage company. The plaintiff was a child with the fetal alcohol syndrome. The child was microcephalic, severely mentally retarded, had the characteristic behavioral pattern of the children who have been severely affected by alcohol in utero, and many other physical and behavioral characteristics, typical of the classical fetal alcohol syndrome. All three of us participated without charging any fees for our time spent on this case. Harold Kalter was a defense expert for the alcohol beverage company and testified that the syndrome did not exist. As teratologists who spend our whole life to protect the public from teratogenic exposures and to prevent congenital malformations, it was surprising to see one of our colleagues align themselves with the alcohol industry against a plaintiff’s child who had been severely affected by alcohol exposures. You have to give credit to Dr. Kalter in that he is consistent. What he says in court he also says publicly.
What did Kalter say in his affidavit and his deposition? In his sworn affidavit dated December 8, 1988, he said,
4.	“3.	Kenneth L. Jones has submitted an affidavit to the Court recounting the research conducted by himself and others to determine whether alcohol is a teratogen (i.e., a cause of malformations). In his opinion, “[a] lcohol is a human teratogen, and today it is generally accepted as such by those who study the cause of birth defects” (Affidavit of Jones, P 12).

5.	I disagree with Dr. Jones on both of those points. Although there has been extensive epidemiological and experimental research on the question of whether alcohol is a teratogen, the result to date have been contradictory. Thus, there are scientists who would agree with Dr. Jones and those who, like myself, have a contrary view, and, therefore, regard any conclusions drawn by Dr. Jones and others as to whether prenatal exposure to alcohol causes or leads to major congenital malformations, unusual facial characteristics or retarded physical or intellectual development as tentative at best.

6.	In studies reporting an apparent association between excessive drinking and major congenital malformations unusual facial characteristics or retarded physical or intellectual development the fact that heavy drinking is usually so highly correlated with risk factors, such as drug abuse, cigarette smoking, high caffeine consumption, poor nutrition socio-economic status, unfavorable demographic characteristics and other factors, has made it virtually impossible to determine whether any observed association is attributable to alcohol abuse or to one or more of the behaviors or factors generally accompanying heavy drinking.”

In Kalter’s deposition taken on March 2, 1989, on page 209 he concludes,

“A.	What I have read, and what I have understood from reading broad surveys of the work, have indicated to me that there is no evidence that alcohol causes birth defects.” (Thorpe v. Jim Beam, 1989).

Section 19 is the final section in Kalter’s review. He summarizes this historical review as follows,

“These pages have shown that the causes of major congenital malformations of external origin that have been discovered and are now known are relatively few, and it may perhaps be that further discovery of environmental causes of congenital malformations with major significance has reached a plateau.”

He reiterates in this summary, 

“About the teratogenicity of another venerable condition, diabetes mellitus, there is in the author’s opinion much doubt.”

It should be pointed out that before insulin was available, diabetes was a disease that resulted in a higher incidence of early spontaneous abortions or the inability to get pregnant.
Kalter has listed a very small group of environmental toxicants that cause birth defects. He is convinced that ionizing radiation and organic mercury are teratogens but apparently no other environmental chemicals or physical agents. He may be right but he did not discuss them in his review. The allegations are out there for lead, trichloroethylene, trihalomethane, pesticides, phthalates, bisphenol, herbicides, and acrylamide. Kalter has a knack for a scholarly evaluation and it would have been nice to have him discuss these agents, since they are controversial and in the news. Among the drugs, he lists the following as teratogens, thalidomide, retinoids, certain anticonvulsants, and folic acid antagonists. He also lists agents, which he considers not to be teratogens, excess vitamin A was the first one. There is no question that vitamin A in vitamin preparations is not teratogenic and probably substantially above the exposure that one could get from eating liver or high dose vitamin pills. But there is also no question that there is a dose of vitamin A, that is teratogenic if administered to a pregnant woman at the right time in pregnancy. The remoteness of this possibility supports Kalter’s conclusion that vitamin A in the usual exposures is not a human teratogen. He does not believe that, Bendectin, blighted potatoes, hyperthermia, DES, female sex hormones, dioxin and other environmental contaminants, lithium, many anticonvulsants, alcohol are teratogenic agents. 
“The answer is that much study has found no consistent evidence that any of them causes major congenital malformations.” 

He critiques Shepard’s recent catalog of teratogenic agents for including DES, lithium, and cigarette smoking in the preface of that book as human teratogens or human reproductive toxins. I think the data is very clear that cigarette smoking can decrease fetal weight and there is an increase in spontaneous abortion or placental separation in mothers who are heavy smokers. 
In his final paragraph he makes two important points. One is that we may never know the etiology of all birth defects and that when we solve the riddle of the genetics of embryonic development and eliminate all environmental teratogens, there still may be a certain percentage of children who will be born with birth defects. I agree with Dr. Kalter on this point and wrote about this first in 1964 and likened some birth defects to the concept of spontaneous mutations; namely, that embryonic development is a very complicated process and that one cannot expect perfection in getting every cell in the right place at the right time. Therefore, we may never be able to eliminate all birth defects. 
Critique
	Throughout my discussion of this review article by Kalter, I have made a number of comments but I would like to review the analysis, now that I have completed reading the manuscript
	First of all this is a monumental effort on the part of Dr. Kalter. The references themselves are a valuable resource. Unfortunately, the draft that I have may not be complete because there are many references in the manuscript that are not in the bibliography and there are some references in the bibliography that are not in the manuscript. I hope that this will be corrected before the final document is published. 
	Secondly, Kalter is a wonderful writer. I think he has a little of William F. Buckley in his soul. But it adds to the poetry of his writing and for those who may not understand some of the words that he uses, you can always use a dictionary and, therefore, expand your vocabulary. 
	Are there omissions that I consider important? There certainly are. He has not discussed a large of number of environmental toxicants and medications that are considered to be teratogenic. The reviewer wonders as to whether he thinks they are less important than the agents that he has mentioned or that he does not consider them to be a teratogen, as he did with DES and lithium. Of course, I cannot answer that question but I can list the agents that I feel should be in a manuscript that is reviewing the human teratogens that were of concern in the 20th century. He may not have mentioned some of these because he does not consider the malformations that are produced as important or because he feels the exposures are so infrequent that they can be ignored. But as teratologists, we usually have the philosophical concept that we should be interested in preventing malformations in one human being and, therefore, should not be concerned only about the magnitude of the problem.
Androgens can cause masculization depending on what stage of gestation the exposure occurs and they are not used presently, but androgens can be produced by tumors within the pregnant woman that can result in masculization of the female fetus which Kalter mentions in his review. Angiotensin converting enzyme inhibitors, also called ACE inhibitors, produce a severe syndrome, which is lethal in many instances when the exposure occurs in the second or third trimester. This is an interesting discovery because it represents a fetopathic drug that does not harm the embryo in the first trimester but seriously affects the fetus.
Antituberculosis therapy was a subject discussed by Dr. Warkany (1979), one of Dr. Kalter’s colleagues and he indicated that there was an increased risk for some CNS abnormalities, following treatment with INH and PAS. When cobalt was present in vitamin preparations, it resulted in fetal goiter. Cocaine produces vascular disruptive malformations in a very low incidence and sometimes pregnancy loss. In any small group of patients exposed to cocaine you may not see an effect. 
Corticosteroids in the human are controversial. There are recent studies that indicate a low risk for cleft palate. This of course, should be of interest to Dr. Kalter since this was one of his areas of research. 
Warfarin results in congenital malformations in two stages of pregnancy. Early exposures during pregnancy can result in nasal hypoplasia and stippling of the secondary epiphyses and intrauterine growth retardation. CNS malformations can occur in late pregnancy exposure due to bleeding. 
Cyclophosphamide and some other chemotherapeutic agents and immunosuppressants such as, cyclosporin or leflunomide have the potential for harming the embryo although many of these are given at an exposure below the threshold for producing birth defects, but they are of concern and every new chemotherapeutic agent has to be considered a potential teratogen.
Minoxidil is an anti-hypertensive drug that was used during pregnancy and it produces a very peculiar effect; namely, hersutism in the newborn. It is certainly not a teratogen in the usual sense and furthermore, the hersutism disappears during the development of the baby in the first year of life.
Methimazole is another drug that Kalter might not agree is a human teratogen, but the data is not clear-cut with regard to certain malformations and especially aplasia cutis. We do not have a mechanism for this malformation but it should be discussed when you are talking about teratogenicity in the 20th century.
Misopostol and chorionic villous sampling (CVS) result in a low incidence of vascular disruptive phenomena such as, limb reduction defects and the Mobius syndrome in women who have attempted abortion medically. 
Progestin therapy – some of the progestins that are derived from the group of androgens when given in very high doses can masculize and produce clitoral hypertrophy. Again, this is not a serious malformation because there are no other effects of high dose progestin therapy and most progestins do not virilize. 
Propylthiouracil given to a mother during pregnancy can result in a goiter in the newborn. Kalter does not mention radioactive isotopes like 131I, which can destroy the thyroid when administered to mother for the treatment of thyroid cancer or hyperthyroidism during pregnancy.
Tetracycline does not produce serious congenital malformations but it does stain the teeth and bones and in very high dosages can effect the structure of the teeth.
Trimethorpin is an interesting drug because it produces folic acid deficiency in adults who are being treated with the drug and it has been reported to increase the risk of neural tube defects in recent publications.
Trimethadione - While trimethadone is not used anymore as an anticonvulsant, it was a potent teratogenic agent and from a historical perspective, it might have been appropriate to include it in the list of human teratogens. 
Recent articles dealing with carbon monoxide have been ambivalent about its effect on the developing fetus and in fact a recent review by Gideon Koren indicates that they really do not have evidence that carbon monoxide poisoning will affect the developing fetus’s central nervous system. But the exposure can have such a wide range that you probably cannot conclude a generalization about CO fetotoxicity
Lead in very high dosages; namely, lead poisoning in the mother has resulted in pregnancy loss in exposures that occurred at the turn of the century or in the 19th century.
In the list of infections, Kalter did mention some of the known infections that affect the fetus but he did not mention parvovirus B19, syphilis, Venezuelan equine encephalitis, and human immunodeficiency virus as infectious agents that may affect the fetus or newborn. With regard to maternal disease states, he just mentions a few but he did not mention the autoimmune diseases, which can have an impact on embryonic and fetal development. Patients with lupus erythematosis have a serious problem with prematurity and sometimes their children are born with heart block, which may never disappear. The women also have a higher incidence of embryonic loss and prematurity.
I remember well the book that Dr. Kalter wrote in the 1960’s dealing with the teratology of the central nervous system. It is a classic. It is well organized and very complete with an excellent review of the literature. This particular manuscript is not as well organized and it appears that some of the sections were written in a stream of consciousness where one section does not even lead into the next section.
There are many famous teratologists who are barely mentioned in this manuscript and yet, Dr. Kalter is one of the most cited authors in this review. Denis New, the discoverer of embryo culture who has had a monumental impact on experimental teratology research is not mentioned. Patty Rodier, who will be delivering the Warkany Lecture at the 2003 meeting concerning her work on the central nervous system is not mentioned. The contributions of Slikker, Kavlock, Cordero, Schwetz and many others are not mentioned. Ronald Jensh, whose papers dealing with radiation in the areas of microwave, ultrasound, and ionizing radiation and the neurobehavioral effects of these entities is not mentioned. Norman Klein, who was a colorful member of the Teratology Society and who brought methionine to our attention as an important amino acid involved in embryonic development is missing. John Lloyd’s work is mentioned along with Beck in their 1966 review on Trypan blue but Kalter stated that we have not worked out the mechanism of action of Trypan blue. If Kalter had followed Beck and Lloyd’s work he would have learned that they had worked out the mechanism of teratogenicity and they opened the field of pinocytosis and the transport of maternal serum proteins to the developing embryo. 
Along with maternal disease states, is the problem of abnormal uterine size, shape as well as, the bifid uterus, enlarged uterine myoma and twin pregnancies. These mechanical problems interfere with embryonic development in a small percentage of cases that result in deformation such as, abnormal skull shapes and limb reduction defects. Vascular disruptive phenomena occur rarely in utero and are responsible for limb reduction defects and other congenital malformations. In most instances the etiology is unknown but they are an entity unto themselves. Kalter does not discuss the amniotic band syndrome, which is not a rare event in embryonic and fetal development and is responsible for surface malformations in the embryo and fetus. There are a number of hypotheses to explain this group of malformations and it includes amnionitis, intrauterine infections, as well as, placental emboli, fetal vascular spasm, and thrombosis. 
This review of Teratology in the 20th century is one scientist’s perspective of the field with many omissions and inaccuracies. But I love the references, even if many of my distinguished colleagues and contributors to the field of Teratology are barely mentioned or not mentioned at all.
Dr. Kalter’s historical perspective on “Teratology in the 20th Century Environmental Causes of Congenital Malformations in Humans and how they were established” has many positive aspects. But it is not a historical review for a number of reasons. When a scientist assumes the responsibility of becoming a historian, he has to assume a much different approach than when you are writing a scientific article in his or her area of expertise. It is not uncommon that research articles include a high proportion of citations and references of the author, since he or she is writing about research in his or her field. When you become a historian you have to become more objective or at least somewhat objective about the contributions of all of the scientists in the field. Kalter has failed as a historian because he has ignored numerous important contributions and contributors to the history of teratology. In this review, Kalter is one of the most cited authors, with over 120 citations to himself. When writing a history, objectivity concerning the contributions of all participants is essential. Dr. Kalter has given the reader his perspective of the field, not as a historian. Much of the criticism offered in this critique would be unnecessary of Kalter had called this monograph, “One Scientist’s Perspective on some of the Teratology Discoveries and Allegations of the 20th Century.” By using he word some he would have indicated that this was his personal perspective and not a history of Teratology in the 20th century.
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